Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 189-191, 1997;
This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yukawa, N.
Right arrow Articles by Moran, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yukawa, N.
Right arrow Articles by Moran, R. F.
Related Collections
Right arrow Hematology
(Clinical Chemistry. 1997;43:189-191.)
© 1997 American Association for Clinical Chemistry, Inc.


Letters

Data Processing in CO-Oximeters That Use Overdetermined Systems

Nobuhiro Yukawa1,a, Takashi Suzuoka2, Takeshi Saito1, Alexander R. W. Forrest3, Motoki Osawa1 and Sanae Takeichi1

1 Dept. of Forensic Med., Tokai Univ. School of Med., Isehara, Kanagawa 259–11, Japan,
2 School of Computer Sci., Carnegie Mellon Univ., Pittsburgh, PA 15213,
3 Dept. of Clin. Chem., Royal Hallamshire Hosp., Sheffield S10 2JF, UK.
a Author for correspondence.


To the Editor:

CO-oximeters are specialized spectrophotometers that automatically determine hemoglobin (Hb) derivatives by measuring absorbance at selected wavelengths (1). We believe that a good understanding of the relevant theory may allow users to avoid many pitfalls during operation of these instruments. The mathematical basis of their operation has not, however, been fully explained by the manufacturers apart from Instrumentation Laboratory (Lexington, MA) at the introduction of their first CO-OximeterTM (2). Here, we discuss what mathematical methods for data processing might be used in commercial CO-oximeters, particularly in those models that use an "overdetermined" system.

CO-oximeters depend on the observation that Hb solutions obey the Lambert–Beer Law; thus, the absorbance measured at a given wavelength is the sum of the absorbance of each Hb derivative at the same wavelength (2). When we measure n wavelengths to determine the m Hb derivatives {chi}i, we get n equations:

(1)
where Aj is the absorbance at wavelength {lambda}j, Ci is the concentration of derivative {chi}i, and l is the pathlength. {epsilon}ji is the molar absorptivity at wavelength {lambda}j for derivative {chi}i.

When n = m, we can solve Eq. 1Up to get Ci. This is termed an "exactly determined" system (3) and has been implemented in the IL 482 CO-Oximeter (Instrumentation Laboratory), the IL 282 (its predecessor), and the Radiometer OSM3 HemoximeterTM (Radiometer, Copenhagen, Denmark). The IL 482 uses four wavelengths for four Hb derivatives, whereas the OSM3 uses six wavelengths for six unknowns: five Hb derivatives plus one for noise (attributed to "turbidity"). The report by Steinke and Shepherd (4) illustrates how the full exposition of the algorithms used in specific instruments is useful not only to users but also to manufacturers. After measuring absorptive spectra of Hb derivatives at three different temperatures, Steinke and Shepherd applied their data to simulate the effect of temperature variation on the accuracy of the IL 482, according to the published mathematical formula. They found that significant errors occurred if the apparatus was not temperature-controlled. The marketed IL 482, however, precisely controls the temperature of the measuring cell.

When n > m, the set of equations for Eq. 1Up has been described as an "overdetermined" system (3). Overdetermined systems have been utilized in the Corning 270 CO-oximeter (Ciba Corning Diagnostic Corp., Medfield, MA), the Corning 2500 (its predecessor), and the AVL 912 CO-OxyliteTM (AVL Scientific Corp., Roswell, GA). The Corning 270 uses 7 wavelengths for five Hb derivatives, whereas the AVL 912 uses 17 wavelengths for five Hb derivatives.

We suspect that these CO-oximeters with overdetermined systems use the least-squares method for data reduction. In such cases, errors dj are defined as the difference between observed value Aj and the predicted values

(2)
The sum of the squared errors S is then given by:

(3)

where {omega}j is the weighting factor,



and r is a constant independent of Ck. The value S is minimized when the partial equations {partial}S/{partial}Ck = 0 (for 1 <= k <= m) hold true. By solving these simultaneous equations, we can get Ci:

(4)
where

and p-1ik is the element for the inverse matrix of the square matrix [pki].

According to standard mathematical textbooks, the usual way to fix the weighting factor {omega}j is to use the inverse of the standard error {sigma}j of absorbance Aj at wavelength {lambda}j ({omega}j = 1/{sigma}j for 1 <= j <= n), if we can determine {sigma}j. Although we cannot determine the standard error for blood samples because of the heterogeneity in their content of Hb derivatives, we can determine the standard error for any (essentially) pure Hb derivative by experiment. We therefore estimate the standard errors {sigma}j for a particular blood sample by assuming that {sigma}j at a given wavelength is the total of the standard error due to each Hb derivative at the same wavelength:

(5)
where {sigma}ji(Ci0) (for 1 <= i <= m, 1 <= j <= n) is the standard error at wavelength {lambda}j for a pure Hb derivative {chi}i having the concentration Ci0, and Ci is the concentration of the Hb derivative {chi}i in the blood sample. The problem with these formulas is that they include Ci, which is the very unknown to be determined. This problem can be avoided by using the following algorithms:

1) Fix all the initial weighting factors as 1 [{omega}j (1) = 1, for 1 <= j <= n].

2) Calculate the provisional concentration Ci(1) from the measured absorbance Aj (1 <= j <= n) by using Eq. 4Up .

3) Calculate the provisional standard error {sigma}j(1) from Ci(1) by using Eq. 5Up .

4) Replace {omega}j(1) with {omega}j(2) = 1/{sigma}j(1).

5) Calculate the next provisional concentration Ci(2).

6) Calculate the next provisional standard error {sigma}j(2) from Ci(2).

7) Repeat 4), 5), and 6) until {omega}j and Ci converge.

Clearly, there may be other possibilities.

Brown (2) attributed a primary cause of the measurement error to the drift in the wavelength of the emitted light ("wavelength shift"). This suggests that the standard error {sigma}j may be linear with respect to the slope (first derivative) of the absorbance spectrum dA/d{lambda} (where {lambda} = {lambda}j). If we accept this assumption, we notice that Eq. 5Up overestimates the standard error {sigma}j for a blood sample because the standard error of each Hb derivative in the sample could cancel out each other (the slope of the absorbance spectrum for the mixture of Hb derivatives is the total of the slope for each Hb derivative in the mixture only when the directions of the slope for all Hb derivatives are the same). On the other hand, we can measure absorbance Aj accurately when Aj falls in a given range (the background noise due to any turbidity produces large errors when Aj is too small, and the upper limit for Aj depends on the linearity of the photooptical system). Considering all of these factors, we suggest that the standard error is a function of the absorbance and of its first derivative: {sigma}j = F(Aj, dA/d{lambda}) (where {lambda} = {lambda}j). However, speculation as to the form of the function F is beyond our ability.

We ask the two companies who use overdetermined systems (Corning and AVL) to comment on this approach—in particular, as to whether the least-squares method is, in fact, used for processing an overdetermined data set. If it is, we hope the manufacturers would explain how they fixed their weighting factors {omega}j, i.e., how they have weighted the redundant wavelengths to achieve more accurate results.


References

  1. Mahoney JJ, Vreman HJ, Stevenson DK, van Kessel AL. Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with Reference Methods. Clin Chem 1993;39:1693-1700. [Abstract]
  2. Brown LJ. A new instrument for the simultaneous measurement of total hemoglobin, % oxyhemoglobin, % carboxyhemoglobin, % methemoglobin, and oxygen content in whole blood. IEEE Trans Biomed Eng 1980;27:132-138. [ISI][Medline] [Order article via Infotrieve]
  3. Zwart A, Buursma A, van Kampen EJ, Zijlstra WG. Multicomponent analysis of hemoglobin derivatives with a reversed-optics spectrophotometer. Clin Chem 1984;30:373-379. [Abstract]
  4. Steinke JM, Shepherd AP. Effects of temperature on optical absorbance spectra of oxy-, carboxy-, and deoxyhemoglobin. Clin Chem 1992;38:1360-1364. [Abstract/Free Full Text]

A manufacturer replies:

Jacques A. Brunelle and Robert F. Morana

Chiron Diagnostics Corp., Medfield, MA 02052
a Author for correspondence.


To the Editor:

We have read the letter of Yukawa et al., and believe that it clearly addresses some often misunderstood aspects of CO-oximetry. We offer what we believe to be some additional perspectives on the topic.

The technique of "least-squares" analysis of error is firmly grounded in the technical and analytical literature and can be a powerful tool in the simultaneous multicomponent analysis used in CO-oximetry. We believe, however, that the rationale for wavelength selection and the use of weighting factors is not quite so clear. In that light we offer the following discussion based on our experience over the several generations of CO-oximeters that Chiron Diagnostics (formerly Ciba Corning Diagnostics) has developed and manufactured.

Wavelength selection for a determined system is a conceptually simple process. One chooses a combination of absorption maxima and isosbestic points, with a total number of wavelengths equal to the number of components of interest. After experimental determination of the absorptivities, one can set up a matrix for solving for the various fractions of a test specimen.

The process for an overdetermined system is similar, except that one decides on an arbitrary number of additional wavelengths, then tests the system in the presence of typical interferents using the least-squares approach. When one has a choice of wavelengths, the process is repeated multiple times to determine the best set of wavelengths to combine measurement of fractions and minimization of the effects of interferents. As a part of the process, one might decide, on the basis of the results of the experimental findings, that either different wavelengths or a greater or lesser number are more robust than those originally selected.

The seven wavelengths used in the M270 CO-oximeter as used by Yukawa et al. have performed quite well for the vast majority of blood samples. However, after years of operation with many hundreds of field placements, it became evident that a small number of blood samples from apparently normal donors have significant deviations in their absorbance spectra in the region between 580 and 610 nm. These deviations resulted in small changes in the reported Hb fractions as well. Although this region of the spectrum would appear to be useful for differentiating MetHb from the other fractions, it introduced unwanted variability in the results. Avoiding this variable region of the Hb spectrum is one of the reasons that led us to select a different set of 10 wavelengths for the new 800 Series CO-oximeter.

Although it is customary to use the standard error or variance of observations as weighting factors for least-squares analysis, it is often difficult to measure or estimate appropriate weighting factors to be used in real applications. Such is the case with CO-oximetry. As Yukawa et al. suggest, the standard error cannot be determined before the measurement because it depends on the actual concentrations of the components being measured. As they also suggest, the standard error could be estimated from measurements on donor samples and then applied to unknown samples in some iterative scheme. However, such an approach can account for only systematic errors in the measurement of absorbances and the variability in wavelength.

Our experience shows that for the measurement of typical blood samples, i.e., samples that are fresh and free of interfering substances and contamination, weighting factors of 1.0 yield both precise and accurate results. The systematic errors that affect all measurements in some measurable or estimatable manner have been minimized. It is the errors resulting from exceptional conditions such as interfering substances and improper preanalytical sample handling that cause the majority of inaccuracy and imprecision. Thus, our approach has been to select wavelengths that avoid many common interferents and minimize susceptibility to minor variations in wavelength.

Of course, it is not possible to avoid all interferents, so detection and correction algorithms have been devised for some known interferents such as lipid, SulfHb, CNMetHb, and methylene blue. For samples that contain uncharacterized interferents, the overdetermined measurement affords a "quality-of-fit index" that is used to detect the presence of unknown interferents and flag the samples with the message, "If blood, question data."

Yukawa et al. have clearly outlined the mathematics behind CO-oximetry measurements with overdetermined systems. However, we feel that the wider system issues of wavelength selection and detection of atypical samples also play an equally vital role in the performance of CO-oximeters. Hopefully this discussion has helped to enlighten users in regard to the characteristics and analytical limitations of present-day CO-oximeters.





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yukawa, N.
Right arrow Articles by Moran, R. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yukawa, N.
Right arrow Articles by Moran, R. F.
Related Collections
Right arrow Hematology


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS